# Ditto Biosciences Landing Page Growth Score | YC W26 | Lazyweb

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-w26/ditto-biosciences
Source observed: 2026-10-08T02:48:45.867Z
Last checked: 2026-10-20T08:08:35.63+00:00
Indexed: 2026-10-08T05:38:01.857+00:00

---

# Ditto Biosciences Landing Page Growth Score

[Back to YC W26](https://www.lazyweb.com/yc-w26)

[Ditto Biosciences](https://www.dittobio.com/)

We assess Ditto Biosciences’ landing page across trust, CTA, value propositions, mobile web, and information hierarchy.

## Overall score and ranking

Ditto Biosciences has a **Growth Score of 63**. The weakest category is **Trust**, scored at **55**. The score was updated **Sep 23, 2026**.

| Category | Score |
|---|---:|
| Trust | 55 |
| CTA | 62 |
| Value props | 62 |
| Mobile web | 62 |
| Information hierarchy | 76 |

In the overall comparison:

1. [Sonoma Biotherapeutics](https://www.lazyweb.com/growth-score/site/sonomabio.com) — 66
2. Ditto Biosciences — 63
3. [Parallel Bio](https://www.lazyweb.com/growth-score/site/parallel.bio) — 57
4. [Holoclara](https://www.lazyweb.com/growth-score/site/holoclara.com) — 57
5. [Seismic Therapeutic](https://www.lazyweb.com/growth-score/site/seismictx.com) — 51

[Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Score over time

The page includes a Growth Score history chart comparing Ditto Biosciences with Parallel Bio, Holoclara, Sonoma Biotherapeutics, Pandion Optimum (Enosi Life Sciences alternative) — Nuvig Therapeutics, and Seismic Therapeutic.

## Trust — 55, Fair

Trust measures proof that the product is real, competent, and safe to try.

![Ditto Biosciences landing-page capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/dittobio.com.jpg?v=2026-09-23T00%3A45%3A28.507%2B00%3A00)

The Ditto Biosciences trust signal shown is a **“Backed by Y Combinator”** badge with a **Launch YC upvote count of 161**. The comparison table includes these trust reads:

| Company | Trust read |
|---|---|
| Ditto Biosciences | “Backed by Y Combinator” badge with Launch YC upvote count (161) |
| Parallel Bio | No visible trust signal identified. |
| Holoclara | “We develop novel therapeutics derived from symbiotic organisms that modulate inflammation, metabolism, and tissue regen” |
| Sonoma Biotherapeutics | “We are building upon decades of foundational, Nobel-winning research established by our founders.” |
| Seismic Therapeutic | “Seismic Therapeutic™ is a clinical-stage immunology company creating transformative biologic medicines for autoimmune a” |

Trust ranking:

1. Sonoma Biotherapeutics — 64
2. Ditto Biosciences — 55
3. Seismic Therapeutic — 44
4. Holoclara — 42
5. Parallel Bio — 38

[Build proof section](https://www.lazyweb.com/backlog?site=dittobio.com#opt-trust-signals) to choose proof signals and get copy and placement for a stronger trust section.

## CTA — 62, Fair

The CTA assessment examines copy, size, verb, and cost-feel.

The displayed CTA is **“Contact us”**. Identified problems:

- “Contact” promises cost, not value.
- No payoff is named for the click.
- The orange blog link competes for attention.

CTA ranking:

1. Ditto Biosciences — 62
2. Holoclara — 58
3. Sonoma Biotherapeutics — 58
4. Parallel Bio — 52
5. Seismic Therapeutic — 42

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=dittobio.com#opt-cta-writing) for primary and secondary CTA options grounded in Ditto Biosciences’ offer and visitor objections.

## Value props — 62, Fair

The landing-page headline is:

> **Evolutionary therapies for autoimmune disease**
>
> “We discover new drugs by harnessing parasite biology.”

What is working:

- The disease area is named plainly.
- Parasite biology is a distinct hook.
- The YC badge adds early credibility.

What could improve:

- No patient or partner outcome is named.
- There are no specifics about diseases, targets, or stage.
- The hero icon decorates but shows nothing.

Value-proposition ranking:

1. Ditto Biosciences — 62
2. Holoclara — 62
3. Sonoma Biotherapeutics — 62
4. Seismic Therapeutic — 52
5. Parallel Bio — 48

## Mobile web — 62, Fair

![Mobile web annotations on the mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/dittobio.com-mobile.jpg?v=2026-09-23T00%3A45%3A28.507%2B00%3A00)

The mobile findings are:

1. **Stacked YC badges** — Two redundant Y Combinator widgets consume the top of the hero and push the CTA down.
2. **Uncollapsed nav row** — A full desktop link row with social icons instead of a hamburger crowds the mobile header.
3. **Contact us button** — A desktop-sized button sits far below the fold; it should be full-width and visible in the first viewport.
4. **Blog link below CTA** — The orange “Check out our first blog” link competes with and sits directly under the primary CTA.

[View mobile fixes](https://www.lazyweb.com/backlog?site=dittobio.com#opt-mobile-web) to convert these findings into a prioritized implementation checklist.

## Information hierarchy — 76, Fair

![Information hierarchy annotations on the desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/dittobio.com.jpg?v=2026-09-23T00%3A45%3A28.507%2B00%3A00)

The identified hierarchy issues are:

1. **Orange blog callout** — Its saturated orange makes it the brightest element in the fold, outranking the navy Contact us CTA and pulling attention to the blog before the pitch.
2. **Launch YC vote widget** — A clickable off-site upvote control above the headline adds an exit path without a conversion payoff; the adjacent badge already conveys the YC credential.
3. **Nav social icons** — LinkedIn and X icons in the header send visitors off-site before they read the headline; footer placement would remove two exits.

[View layout plan](https://www.lazyweb.com/backlog?site=dittobio.com#opt-information-hierarchy) to turn these callouts into a sequenced keep, move, merge, or remove plan.

## Competitors

The comparison is inferred from product, audience, and value proposition.

1. [Sonoma Biotherapeutics](https://www.lazyweb.com/growth-score/site/sonomabio.com) — sonomabio.com — 66
2. Ditto Biosciences — 63
3. [Parallel Bio](https://www.lazyweb.com/growth-score/site/parallel.bio) — parallel.bio — 57
4. [Holoclara](https://www.lazyweb.com/growth-score/site/holoclara.com) — holoclara.com — 57
5. [Seismic Therapeutic](https://www.lazyweb.com/growth-score/site/seismictx.com) — seismictx.com — 51
6. [Pandion Optimum (Enosi Life Sciences alternative) — Nuvig Therapeutics](https://www.lazyweb.com/growth-score/site/nuvig.com) — nuvig.com — failed

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-w26%2Fditto-biosciences&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-w26%2Fditto-biosciences). Opening a form does not execute a tool.